Treatment of Mild-moderate Clostridium Difficile Infection (CDI)

NCT04121169 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Clostridium Difficile Infection (CDI)

Interventions

DRUG: IM-01

Sponsor

ImmuniMed Inc.

Collaborators

[object Object]
[object Object]